Problem 7
Question
The diagnosis of type 2 diabetes is made through an oral glucose tolerance test. Briefly describe the glucose tolerance test and the criteria used to establish type 2 diabetes. What are the criteria for impaired glucose tolerance without type 2 diabetes?
Step-by-Step Solution
Verified Answer
The oral glucose tolerance test is a diagnostic tool for type 2 diabetes where a patient's blood glucose level is measured before and after consuming a specified amount of glucose. Diabetes is diagnosed if the fasting blood glucose is \( \geq \) 7.0 mmol/L or if the 2-hour blood glucose is \( \geq \) 11.1 mmol/L. Impaired glucose tolerance is diagnosed if the fasting glucose level is \( < \) 7.0 mmol/L and the 2-hour glucose level is between 7.8 and 11.1 mmol/L.
1Step 1: Explanation of the Glucose Tolerance Test
An oral glucose tolerance test (OGTT) is a medical procedure used to diagnose cases of diabetes mellitus. The procedure begins with a patient fasting overnight. Upon coming to the health center, a blood sample is taken to measure the fasting blood glucose level. The patient then consumes a specified amount of glucose, traditionally in liquid form. Subsequent blood samples are taken at various time intervals, typically at 30 minutes, 1 hour, 2 hours, and 3 hours post glucose intake.
2Step 2: Establishing Criteria for Type 2 Diabetes
The World Health Organization (WHO) provides the following criteria for a diagnosis of diabetes based on the OGTT. A positive diagnosis is made: 1. If the fasting plasma glucose level is \( \geq \) 7.0 mmol/L (126 mg/dL)2. Or if the 2-hour post glucose intake plasma glucose level is \( \geq \) 11.1 mmol/L (200 mg/dL). Individuals must meet at least one of the two conditions for a diagnosis of diabetes.
3Step 3: Criteria for Impaired Glucose Tolerance (IGT)
Impaired Glucose Tolerance (IGT) is a pre-diabetic state. According to the WHO, a person is said to have IGT if: 1. They have a fasting plasma glucose level \( < \) 7.0 mmol/L (126 mg/dL) and 2. Their 2-hour plasma glucose level in the OGTT is between 7.8 and 11.1 mmol/L (140 and 200 mg/dL).
Key Concepts
Oral Glucose Tolerance TestFasting Plasma Glucose LevelImpaired Glucose Tolerance
Oral Glucose Tolerance Test
The Oral Glucose Tolerance Test (OGTT) is a key procedure in diagnosing diabetes, particularly type 2 diabetes. It involves measuring the body's ability to manage glucose after a period of fasting and then after consuming a glucose-rich drink. Here's how it works: after fasting overnight, a patient's fasting plasma glucose level is recorded. Then, the patient consumes a prescribed amount of glucose. Blood samples are taken at intervals to track how glucose levels change over time. The typical timeline includes blood samples at 30 minutes, 1 hour, 2 hours, and 3 hours after glucose consumption.
The results from these intervals can reveal how efficiently a person's body is processing glucose, which is crucial for energy production. Inefficient glucose processing might indicate diabetes. Healthcare professionals use the data from an OGTT to confirm a diagnosis and to understand a patient's glucose metabolism better.
The results from these intervals can reveal how efficiently a person's body is processing glucose, which is crucial for energy production. Inefficient glucose processing might indicate diabetes. Healthcare professionals use the data from an OGTT to confirm a diagnosis and to understand a patient's glucose metabolism better.
Fasting Plasma Glucose Level
The fasting plasma glucose level is a critical measure in the diagnosis of diabetes. It is the concentration of glucose in a person's blood after at least eight hours without eating or drinking anything except water. This test provides a snapshot of how the body regulates blood glucose levels when in a fasting state.
To undergo the test, patients must fast overnight. The next morning, a blood sample is taken to measure the glucose. If the fasting plasma glucose level is 7.0 mmol/L (126 mg/dL) or higher, it could indicate diabetes, based on the criteria set by the World Health Organization (WHO). A normal fasting blood sugar level is lower than 6.1 mmol/L (110 mg/dL). Values between these ranges may suggest a transition phase known as impaired fasting glucose, which can precede diabetes.
To undergo the test, patients must fast overnight. The next morning, a blood sample is taken to measure the glucose. If the fasting plasma glucose level is 7.0 mmol/L (126 mg/dL) or higher, it could indicate diabetes, based on the criteria set by the World Health Organization (WHO). A normal fasting blood sugar level is lower than 6.1 mmol/L (110 mg/dL). Values between these ranges may suggest a transition phase known as impaired fasting glucose, which can precede diabetes.
Impaired Glucose Tolerance
Impaired Glucose Tolerance (IGT) is a term used to describe a condition where the body shows signs of disrupted glucose metabolism, which is a hallmark of pre-diabetes. It is neither normal glucose tolerance nor full-blown diabetes, but rather a middle ground where blood glucose levels are higher than normal after ingesting glucose but not high enough for a diabetes diagnosis.
According to the WHO's criteria, a person with a fasting plasma glucose level below 7.0 mmol/L (126 mg/dL) and a 2-hour plasma glucose level in the OGTT between 7.8 and 11.1 mmol/L (140 and 200 mg/dL) is considered to have IGT. Identifying IGT is important because it allows for early intervention that can prevent or delay the progression to type 2 diabetes. Lifestyle modifications, such as exercise and diet changes, are often recommended to manage IGT.
According to the WHO's criteria, a person with a fasting plasma glucose level below 7.0 mmol/L (126 mg/dL) and a 2-hour plasma glucose level in the OGTT between 7.8 and 11.1 mmol/L (140 and 200 mg/dL) is considered to have IGT. Identifying IGT is important because it allows for early intervention that can prevent or delay the progression to type 2 diabetes. Lifestyle modifications, such as exercise and diet changes, are often recommended to manage IGT.
Other exercises in this chapter
Problem 5
Describe how coronary artery disease can lead to ventricular fibrillation and death.
View solution Problem 6
Briefly state why prevalence may be better than mortality rate as a measure of cardiovascular disease.
View solution Problem 8
Relate an increase in AGEs to damage caused by type 2 diabetes.
View solution Problem 9
Explain why preventive strategies for osteoporosis target young women (14-30 years old) rather than postmenopausal women.
View solution